MultiMedica Scientific Research

Economic Aspects

Economic facts relating to the testing of new medicinal products or medicinal products not newly established

The sponsor or research fund holder must provide the IRCCS MultiMedica with equipment and inventoryable material not in possession of the facility, consumables and, of course, medicines to be used in the trial.

The sponsor or research fund holder shall not provide that material which does not constitute additional expenditures for the purpose of the trial, is part of the established treatments and interventions provided in the trial.

The sponsor or research fund holder shall ensure adequate insurance cover for trial subjects. The insurance cover is intended to protect subjects from any damage directly or indirectly resulting from the trial.

The sponsor or research fund holder must provide insurance cover for investigators.

The sponsor or research fund holder may not engage in direct bargaining with health care or administrative personnel involved in the trial. The negotiations must be conducted directly with the Institution.

The sponsor or research fund holder must send the necessary medicines for the trial directly to the institution’s pharmacy. The person in charge of the pharmacy will register and store the drugs and deliver them to the investigator.

For each application for evaluation, a fixed secretarial fee will be established for the promoters of the trial, whether they are pharmaceutical or bio-sanitary companies.

Public bodies and/or research institutes are exempt from the payment of the fixed fee (excluding VAT).

  • Royalties for Jurisdiction Judgments and/or Protocols for which MultiMedica is Coordinating Centre or Monocenter 4,000 euro
  • Royalties for Protocols for which MultiMedica is Satellite Center 3,500 €
  • Substantial amendments: 2,000 euro
  • Administrative amendments 800 euro

This right will be credited in the financial statements of IRCCS MultiMedica on a chapter in the name of the Ethics Committee.

Payments must be made by wire transfer in the name of a bank transfer:

MULTIMEDICA Spa – COMITATO ETICO:
Via Milanese 300, 20099 Sesto San Giovanni – Milano

BANCA INTESA SAN PAOLO
filiale MONZA Piazza Trento e Trieste, n.10
IBAN IT 80 T 03069 20407 100000017775
SWIFT: BCITITMM

You are recommended to indicate the title of the Protocol on the reason for payment and the protocol number assigned by the EC